1. Home
  2. NBR vs LENZ Comparison

NBR vs LENZ Comparison

Compare NBR & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nabors Industries Ltd.

NBR

Nabors Industries Ltd.

HOLD

Current Price

$68.90

Market Cap

746.4M

Sector

Energy

ML Signal

HOLD

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$15.56

Market Cap

609.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBR
LENZ
Founded
1952
2019
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
746.4M
609.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NBR
LENZ
Price
$68.90
$15.56
Analyst Decision
Hold
Strong Buy
Analyst Count
8
4
Target Price
$54.13
$56.25
AVG Volume (30 Days)
364.8K
1.2M
Earning Date
02-11-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
14.43
N/A
Revenue
$3,116,983,000.00
$17,500,000.00
Revenue This Year
$9.76
N/A
Revenue Next Year
$0.25
$203.42
P/E Ratio
$4.58
N/A
Revenue Growth
6.52
N/A
52 Week Low
$23.27
$14.43
52 Week High
$70.61
$50.40

Technical Indicators

Market Signals
Indicator
NBR
LENZ
Relative Strength Index (RSI) 68.95 36.47
Support Level $63.23 $14.87
Resistance Level $70.61 $21.80
Average True Range (ATR) 2.72 1.60
MACD 0.04 -0.11
Stochastic Oscillator 83.38 10.02

Price Performance

Historical Comparison
NBR
LENZ

About NBR Nabors Industries Ltd.

Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Share on Social Networks: